nRichDX's VP of R&D Will Present a Poster at the AACR Special Conference in Cancer Research:Bladder Cancer Transforming the Field Meeting. The meeting will be held May 17-20, 2024 at the Le Méridien Charlotte Hotel in Charlotte, North Carolina....
nRichDX's Chief Science Officer Will Attend and Present at the "New Frontiers in Liquid Biopsy Meeting - Data, Technology and Translational Potential" The "New Frontiers in Liquid Biopsy Meeting - Data, Technology and Translational Potential" will be held May 13-14, 2024 at the National Institutes of Health's Bethesda, Maryland Campus in the Natcher Auditorium in Building 45....
See nRichDX at the AACR 2024 Annual Meeting, April 7-10 2024 in San Diego, California....
See nRichDX at the AMP 2023 Annual Meeting & Expo, November 14-18 2023 in Salt Lake City, Utah....
nRichDX is hosting a webinar with keynote presenter Dr. Klaus Pantel on April 12 2023 titled, Current Perspectives on Liquid Biopsy Technologies...
See nRichDX at the AACR Annual Meeting, April 14-19 2023 in Orlando, Florida....
See nRichDX at the 30th Anniversary TRI-CON Meeting on March 6-8 2023 online and in-person in San Diego, California. See the latest in preanalytical solutions for liquid biopsy with the Revolution Sample Prep System....
See nRichDX at the AMP 2022 Annual Meeting and Expo on November 1-5 2022. See the latest in cfDNA and ctDNA extraction with the Revolution Sample Prep System....
Join nRichDX at the upcoming Cancer Genomics Consortium (CGC) 13th Annual Meeting in St. Louis, MO, 31 July - 3 August 2022. The CGC Annual Meeting is a unique gathering aimed at bringing the clinical genomics community together to create an environment of collaboration, education and networking. With the continuing and evolving partnerships between cytogeneticists molecular geneticists, pathologists, oncologists, and bioinformaticians, CGC is committed to playing an essential role in providing guidance on the best practice of genomic testing....
Increase liquid biopsy-based test sensitivity by delivering exponentially more target input for molecular assays...